A 16-year-old boy, presented with gradually progressive, painless swelling over the back for 1-month duration followed by similar swellings over head and chest. He also noticed bulging of the right eyeball with double vision in last 1 week.
RUNX1/RUNX1T1) was made. Because of the deplorable general condition, patient and the family agreed for hypomethylating agents as a bridge to the standard induction therapy. The patient succumbed to the illness after the first cycle of Decitabine due to sepsis and multi-organ dysfunction.
Granulocytic sarcoma (GS), also known as myeloid sarcoma or chloromas have been described since 1811 [1] . Along with leukemia cutis, it is a well-defined extramedullary manifestation of acute myeloid leukemia. It constitutes a collection of immature cells of granulocytic origin and it is seen in 2.5-9.1% of AML cases [2] . Granulocytic sarcoma can precede, concur or follow the AML. It can present as a solitary lesion or multifocal lesion [3] . It can be virtually located in any part of the body and when present confer a poor clinical outcome [4] . Common differential diagnosis includes non-Hodgkin's lymphoma, dendritic cell neoplasm, Ewing sarcoma, and melanoma [5] . Diagnosis depends on morphology, immunohistochemistry and flow cytometry. PET-CT is useful in detecting anatomically hidden GS, planning radiotherapy and assessing the response to therapy [4, 6] . The outcome of chemotherapy alone in patients presenting with granulocytic sarcoma is often disappointing. The standard treatment constitutes induction chemotherapy (7 ? 3) followed by hematopoietic stem cell transplantation [2] . A favorable risk is attributed to patients with t (8:21), and a good prognosis is expected from chemotherapy alone, but the outcome is significantly poor in the presence of GS even in the presence of t (8;14) and thus necessitates HSCT in complete remission after induction chemotherapy [4, 7] .
The index case represents clinically apparent multiple granulocytic sarcoma as presenting feature of AML, which is extremely rare and may confuse the clinician with other solid malignancy. In the absence of clinical suspicion, even the morphological appearances on histopathology may mimic a non-Hodgkin lymphoma and unnecessary delay in diagnosis of one of the most aggressive malignancies that require early diagnosis and prompt therapy.
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